Au 25 (Captopril) 18 nanoclusters (NCs) are a 1.2 nm watersoluble metal nanomaterial with strong two-photon absorption, with excited-state reactive oxygen production, and of potential applicability for biomedical imaging and two-photon photodynamic therapy (2p-PDT). Because of the low cellular uptake of Au 25 (Captopril) 18 clusters, its limited potential for conjugation with targeting agents, and to enhance its biocompatibility, we embedded these clusters into hydrogel nanoparticles (NPs) by synthesizing polyacrylamide-encapsulated Au 25 (Capt) 18 nanoparticles (PAAm-Au 25 (Capt) 18 NPs). We verified that the two-photon absorption and singlet oxygen production of these PAAm-Au 25 NPs still exhibit the favorable properties of the original metal nanocluster. Furthermore, the Au 25 -encapsulated polyacrylamide nanoparticles have enhanced in vitro cell uptake, can be easily conjugated to targeting moieties, and exhibit significantly higher biocompatibility. Photoirradiation experiments on HeLa cancer cells incubated with these PAAm-Au 25 (Capt) 18 NPs reveal excellent 2p-PDT efficacy, in contrast to 1p-PDT, thus demonstrating their promising potential for cancer PDT with infrared light that penetrates deeply into live tissue.

Introduction There remains an unclear definition of the term “gigantomastia,” with many studies using different parameters and measurements. Currently, the operative management and patient education for gigantomastia are outdated. The historical teaching that a free nipple graft is necessary in elongated pedicles to avoid nipple necrosis may not be factual. The principal goal of our review aims to determine the safety of nipple-sparing breast reductions on large ptotic breasts via complication rate analysis. Methods The systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines of conduct for systematic review and meta-analysis. In October 2021, PubMed was used to search the US National Library of Medicine database. Rayyan Intelligent Systematic Review aided in screening studies by title then abstract. If inclusion criteria were met, the entire article was reviewed. Results Twenty-two articles satisfied the inclusion and exclusion criteria. The study was composed of 1689 total patients with a mean body mass index of 32.9 (±3.4). Mean midclavicle-to-nipple distance and resection weight per breast was 39 cm (±3.8) and 1423.8 g (±268.9), respectively. A Wise pattern was preferred in 77.3% of the studies, with an inferior (45.5%) and superomedial (45.5%) pedicle used most commonly. Complete nipple areolar complex necrosis (1.7%) was found in 4 studies, whereas partial (5.9%) was observed in 11. More common complications included delayed wound healing (17.4%), surgical site infection (14.3%), seroma (10.5%), scar hypertrophy (9.9%), and wound dehiscence (9.2%). Conclusion Nipple-sparing breast reduction surgery can be safely performed on hypertrophic and severely ptotic breasts with nipple areolar complications, such as partial or complete nipple areolar complex loss, at a rate less than previously believed.

Exposure to trauma increases the long-term risk of mortality, and experiencing non-fatal physical assault is not an exception. To better understand population heterogeneity in this link, the current study explored Black-White differences in the association between history of non-fatal physical assault and risk of all-cause mortality over a 25-year period in the United States. Data came from the Americans' Changing Lives (ACL) study that followed 3617 non-institutionalized respondents for up to 25 years. History of non-fatal physical assault at baseline was the predictor. Outcome was time to death due to all-cause mortality during follow-up from baseline (1986) to follow-up (2011). Confounders included gender, age, and baseline socio-economic status (education and income), health behaviors (smoking and drinking), and health status (chronic medical conditions, self-rated health, and body mass index). Race was the moderator. Cox regressions were used for multi-variable analysis. History of non-fatal physical assault at baseline was associated with an increased risk of mortality, above and beyond baseline socioeconomic status, health behaviors, and health status. Race interacted with history of non-fatal physical assault on mortality, suggesting a stronger effect for Whites compared to Blacks. In race-specific models, history of non-fatal physical assault was associated with risk of mortality for Whites but not Blacks. The current study showed that experiencing non-fatal physical assault increases the risk of premature death above and beyond demographics, socioeconomic status, health behaviors, and health status. Experiencing non-fatal physical assault may have a larger effect on premature mortality among Whites than Blacks. Future research is needed on how Blacks and Whites differ in the health consequences of social adversities.

No abstract